ACEM26 Logo
  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs
Submit an abstract
ACEM 2025

Gilead Sciences

,

  • Booth no: 32 + 33

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.

The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer.

Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Based in Melbourne, Gilead Sciences Australia and New Zealand employs over 100 people.

Share

Key dates

  • Abstract Submissions Open

    16 March

  • Early Bird Registrations Open

    24 April

  • Abstract Submissions Close

    1 July

  • Abstract Acceptance Notification

    Late August

  • Volunteer Applications Close

    26 August

  • Presenter Acceptance Deadline

    Early September

  • Early Bird Registration Deadline

    7 September

  • Presenter Registration Deadline

    Late September

  • Standard Registration Deadline

    6 November

Related